Shareholder Alert: Morganti Legal and Faguy & Co. Announce Class Action Lawsuit Against Valeant Pharmaceuticals International Inc. (VRX)

Morganti Legal (Toronto) and Faguy & Co. (Montreal), announce that on Monday, October 26, 2015, they issued a class action claim in Quebec on behalf of all investors that purchased the securities of Valeant Pharmaceuticals International Inc. listed on the Toronto Stock Exchange and the Swiss Stock Exchange.  (TSX and SIX: “VRX”).

Investors who purchased shares of Valeant Pharmaceuticals International Inc. on the Toronto Stock Exchange and Swiss Stock Exchange on or before October 21, 2015 are encouraged to stay informed and protect their rights. You may contact Morganti Legal at (888) 226-0845 or by email at [email protected] or Faguy & Co. at (514) 285-8100 or by email at [email protected] for further information.

None of the allegations have been adjudicated in court at this time.

Morganti Legal is comprised of experienced securities lawyers that investigate, litigate and resolve economic and financial disputes. You may learn more about Morganti Legal at www.morgantilegal.com. The Firm currently represents investors that purchased securities of Allied Nevada Gold Corp, BP plc, Detour Gold Corporation, Ithaca Energy Limited, MDC Partners, Inc., Silvercorp Metals Inc., and Tesco plc.

Faguy & Co is a boutique commercial and civil litigation firm. It represents an international clientele and referring law firms worldwide in the jurisdictions of Quebec, Ontario and before the federal courts. To learn more about Faguy & Co. please visit www.faguyco.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

For further information:  Andrew Morganti, (English language) at (888) 226-0845 or by email at [email protected]; Shawn K. Faguy (French language) at (514) 285-8100 or by email at [email protected].